Jay Venkatesan - Nov 26, 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director
Signature
/s/ Jay Venkatesan
Stock symbol
ELTX
Transactions as of
Nov 26, 2024
Transactions value $
$500
Form type
4
Date filed
11/29/2024, 07:39 AM
Previous filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Exercise of in-the-money or at-the-money derivative security $500 +50K +38.59% $0.01 180K Nov 26, 2024 Direct F1
holding ELTX Common Stock 953 Nov 26, 2024 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Warrant to Purchase Common Stock Exercise of in-the-money or at-the-money derivative security $0 -50K -100% $0.00 0 Nov 26, 2024 Common Stock 50K $0.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 26, 2024, the Reporting Person exercised a pre-funded warrant to purchase an aggregate of 50,000 shares of the Issuer's common stock.
F2 The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.
F3 N/A